These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 28808977)

  • 1. Skeletal Dysplasias: What Every Bone Health Clinician Needs to Know.
    Nikkel SM
    Curr Osteoporos Rep; 2017 Oct; 15(5):419-424. PubMed ID: 28808977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The changing world of skeletal dysplasia.
    Calder AD
    Lancet Child Adolesc Health; 2020 Apr; 4(4):253-254. PubMed ID: 32119838
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypophosphatasia: From Diagnosis to Treatment.
    Simon S; Resch H; Klaushofer K; Roschger P; Zwerina J; Kocijan R
    Curr Rheumatol Rep; 2018 Sep; 20(11):69. PubMed ID: 30203264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Asfotase Alfa on Muscle Weakness in a Japanese Adult Patient of Hypophosphatasia with Low ALP Levels.
    Koyama H; Yasuda S; Kakoi S; Ohata Y; Shimizu Y; Hasegawa C; Hayakawa A; Akiyama T; Yagi T; Aotani D; Imaeda K; Ozono K; Kataoka H; Tanaka T
    Intern Med; 2020 Mar; 59(6):811-815. PubMed ID: 31787692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa.
    Kishnani PS; Rush ET; Arundel P; Bishop N; Dahir K; Fraser W; Harmatz P; Linglart A; Munns CF; Nunes ME; Saal HM; Seefried L; Ozono K
    Mol Genet Metab; 2017 Sep; 122(1-2):4-17. PubMed ID: 28888853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asfotase alfa treatment for 1 year in a 16 year-old male with severe childhood hypophosphatasia.
    Bowden SA; Adler BH
    Osteoporos Int; 2018 Feb; 29(2):511-515. PubMed ID: 29046930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antenatal diagnosis of skeletal dysplasia using ultrasound.
    McGuire J; Manning F; Lange I; Lyons E; deSa DJ
    Birth Defects Orig Artic Ser; 1987; 23(1):367-84. PubMed ID: 3555644
    [No Abstract]   [Full Text] [Related]  

  • 8. Reappearance of hypomineralized bone after discontinuation of asfotase alfa treatment for severe childhood hypophosphatasia.
    Bowden SA; Adler BH
    Osteoporos Int; 2018 Sep; 29(9):2155-2156. PubMed ID: 29967930
    [No Abstract]   [Full Text] [Related]  

  • 9. Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial.
    Whyte MP; Simmons JH; Moseley S; Fujita KP; Bishop N; Salman NJ; Taylor J; Phillips D; McGinn M; McAlister WH
    Lancet Diabetes Endocrinol; 2019 Feb; 7(2):93-105. PubMed ID: 30558909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asfotase alfa (Strensiq) for hypophosphatasia.
    Med Lett Drugs Ther; 2016 Jul; 58(1499):e96. PubMed ID: 27403786
    [No Abstract]   [Full Text] [Related]  

  • 11. Improvement of bone microarchitecture parameters after 12 months of treatment with asfotase alfa in adult patient with hypophosphatasia: Case report.
    Freitas TQ; Franco AS; Pereira RMR
    Medicine (Baltimore); 2018 Nov; 97(48):e13210. PubMed ID: 30508901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme Replacement Therapy in Hypophosphatasia.
    Uçaktürk SA; Elmaogullari S; Ünal S; Gönülal D; Mengen E
    J Coll Physicians Surg Pak; 2018 Sep; 28(9):S198-S200. PubMed ID: 30173697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful Use of Enzyme Replacement Therapy in Infantile Hypophosphatasia.
    Simm PJ; Savarirayan R
    J Paediatr Child Health; 2017 Sep; 53(9):925-926. PubMed ID: 28868782
    [No Abstract]   [Full Text] [Related]  

  • 14. [Advances in bone dysplasias].
    Borrego E; Farrington DM; Downey FJ
    Rev Esp Cir Ortop Traumatol; 2014; 58(3):171-81. PubMed ID: 24731388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variable expressivity in the skeletal dysplasias.
    Rimoin DL
    Birth Defects Orig Artic Ser; 1979; 15(5B):91-112. PubMed ID: 526594
    [No Abstract]   [Full Text] [Related]  

  • 16. Specific ultrasonographic features of perinatal lethal hypophosphatasia.
    Zankl A; Mornet E; Wong S
    Am J Med Genet A; 2008 May; 146A(9):1200-4. PubMed ID: 18386808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neonatal hypophosphatasia (author's transl)].
    Sandomenico C; Vaccaro S; Caruso F; Ciaramella F
    Radiol Med; 1978 Dec; 64(12):1365-72. PubMed ID: 754206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a Novel Scoring System for Changes in Skeletal Manifestations of Hypophosphatasia in Newborns, Infants, and Children: The Radiographic Global Impression of Change Scale.
    Whyte MP; Fujita KP; Moseley S; Thompson DD; McAlister WH
    J Bone Miner Res; 2018 May; 33(5):868-874. PubMed ID: 29297597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asfotase Alfa: A Review in Paediatric-Onset Hypophosphatasia.
    Scott LJ
    Drugs; 2016 Feb; 76(2):255-62. PubMed ID: 26744272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery of bone mineralization and quality during asfotase alfa treatment in an adult patient with infantile-onset hypophosphatasia.
    Rolvien T; Schmidt T; Schmidt FN; von Kroge S; Busse B; Amling M; Barvencik F
    Bone; 2019 Oct; 127():67-74. PubMed ID: 31152801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.